Correlation between protein abundances and R_5-20 z-score among cases at baseline. Protein abundances, normalized to mean 0 and variance 1, are displayed on the y-axis. (... حسب Spela Kokelj (8356644)

الموضوعات:

General characteristics and clinical data of the subjects included in the study. حسب Spela Kokelj (8356644)

الموضوعات:

Distribution of average relative amounts of lipid classes. حسب Spela Kokelj (8356644)

الموضوعات:

Flow chart on the inclusion and drop out of patients. حسب Spela Kokelj (8356644)

الموضوعات:

Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls. حسب Spela Kokelj (8356644)

الموضوعات:

Symptoms reported by COVID-19 cases at baseline and at follow-up. حسب Spela Kokelj (8356644)

الموضوعات:

Effects of BM-MSCs on ROS generation in DCS rats. حسب Chen Lu (135200)

الموضوعات:

Pretreatment of BM-MSCs attenuates DCS induced lung inflammation. حسب Chen Lu (135200)

الموضوعات:

Isotype control overlays. حسب Chen Lu (135200)

الموضوعات:

The mean and standard deviation of parameters. حسب Sadaf Sepasgozar Sarkhosh (20436143)

الموضوعات:

Original uncropped blot. حسب Chen Lu (135200)

الموضوعات:

Characterization of BM-MSC. حسب Chen Lu (135200)

الموضوعات:

Pretreatment of BM-MSCs improves the survival rate and incidence of DCS. حسب Chen Lu (135200)

الموضوعات:

Utilization of anticoagulants at eight hospitals from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

The ANCOVA and Post_hoc results. حسب Sadaf Sepasgozar Sarkhosh (20436143)

الموضوعات:

The demographical and clinical characteristics of subjects at baseline. حسب Sadaf Sepasgozar Sarkhosh (20436143)

الموضوعات:

Identification of BM-MSCs. حسب Chen Lu (135200)

الموضوعات:

CONSORT flowchart. حسب Sadaf Sepasgozar Sarkhosh (20436143)

الموضوعات:

Effect of BM-MSCs in improving DCS induced lung injury. حسب Chen Lu (135200)

الموضوعات:

Inpatient utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات: